Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries

Preface.
Acknowledgments.
About the Authors.
Part One The Life Science Industry Context for Portfolio,Program, and Project Management.
1 A Review of Project Management in Life Science IndustrySectors (Thomas R. Dunson).
2 The Impact of Organizational Size on Drug Project Management(Eric Morfin).
3 Drug Development in Biotechnology and How We Can Do It Better(Susan Linna).
Part Two The Portfolio, Program, and Project ManagementApproaches and Processes.
4 An Overview of the Organization and Processes of Portfolio,Program, and Project Management (Pete Harpum).
5 Portfolio Management in the Pharmaceutical Industry: BalancingCorporate Need with the Reality of Delivering Products to theMarket (John Bennett).
6 Program Management in Drug Development (PaulineStewart-Long).
7 Project Control (Martin Powell).
8 Managing Uncertainty in Drug Projects (Pete Harpum andThomas R. Dunson).
9 Managing Drug Safety Risk (Thomas R. Dunson and EricMorfin).
10 Developing Program Strategy (Pete Harpum).
11 Developing Products with "Added Value" (Trevor J.Brown and Stephen Allport).
Part Three Integrating the Processes.
12 Integrated Business Processes to Support Cross-FunctionalDrug Development (Martin D. Hynes III).
13 Integrated Drug Development From Cradle to Grave and From Labto Market (Stephen Allport and Terry Cook-Davies).
14 The Development of P³M Capability in DrugDevelopment Organizations (John Arrowsmith, Patrick Grogan andBob Moore).
15 Implementing Portfolio, Program, and Project Management BestPractices in Drug Development Organizations (Pete Harpum, AshleyJamieson and Inge Fisher).
Bibliography.
Index.